Avidity
Todd McPherron is an accomplished quality assurance professional with extensive experience in the biopharmaceutical industry. Currently serving as the Director of Quality Assurance at Avidity Biosciences, Inc., Todd McPherron oversees GMP quality functions, ensuring compliance and managing quality systems. Previous roles include Senior Director of Quality at Silverback Therapeutics, where Todd was responsible for implementing quality systems across GxP functions, and Director of Quality Assurance at Zymeworks Inc., focusing on quality operations and compliance. Todd has also held key positions at Lundbeck Seattle BioPharmaceuticals and Bristol-Myers Squibb, managing various quality assurance programs and overseeing contract manufacturing organizations. Educational credentials include a Master’s degree in Organic Chemistry from Western Washington University and a Graduate Certificate in Biopharmaceutical Domestic Regulatory Affairs from Northeastern University.
This person is not in any offices
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.